-
-
-
-
-
-
-
Goldman Sachs Adjust Monthly US Director's Cut List
-
-
-
-
-
-
-
Morgan Stanley tracks US drug market prescriptions for week ending July 31
-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $560 at Truist Securities
-
-
-
-
-
-
-
Vertex Pharma (VRTX) call put ratio 1 call to 1.8 puts into acquiring Crinetics
-
-
-
-
-
-
-
Truist Securities Assumes Vertex (VRTX) at Buy
-
-
-
-
-
-
-
Vertex Pharma (VRTX) Tops Q1 EPS by 14c, Misses on Revenue; Offers FY26 Revenue Guidance
-
-
-
-
-
-
-
BMO Capital on Vertex (VRTX): 'Ivacaftor Related Label Updates Unlikely to Impact CF Franchise Strength'
-
468,188 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

